Obesity's Risks Include Cancer, Too

Reprinted with permission, J Natl Cancer Inst, 94:1704-11, 2002 OF MICE AND DUCTS: Ductal branching (arrows), part of normal mammary-gland development, is absent in tissues from leptin-deficient (panel B) and leptin-receptor-deficient (D) mice, but is present in tissues from wild-type controls (A and C). By fostering mammary development, the leptin pathway might contribute to tumorigenesis. An estimated 30.5% of American adults--nearly 59 million people--were obese in 2000, after their r

Written byDouglas Steinberg
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

An estimated 30.5% of American adults--nearly 59 million people--were obese in 2000, after their ranks had swelled 33% since the mid-1990s.1 But growing obesity rates are not confined to the United States, and the attendant health risks do not just include cardiovascular disease, diabetes, asthma, and arthritis. Cancers of the colon, breast, endometrium, kidney, and esophagus also are solidly associated with excess adiposity.2 (A link to prostate cancer is controversial.) In addition, obese patients with cancer have poorer prognoses. Caloric restriction offers some protection against the disease, but eating trends are clearly heading in the opposite direction.

Despite the situation's apparent urgency, only a handful of research-ers are examining the obesity- cancer link through experiments. Instead, the evidence is overwhelmingly epidemiological. The human data and some of the underlying mechanisms are "pretty clear," says Walter C. Willett, professor of epidemiology and nutrition at the Harvard School of Public Health. "It's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies